tocophersolan has been researched along with Myocardial Infarction in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, S; Li, J; Wu, F; Zhang, S; Zhang, X | 1 |
1 other study(ies) available for tocophersolan and Myocardial Infarction
| Article | Year |
|---|---|
Triphenylphosphonium and D-α-tocopheryl polyethylene glycol 1000 succinate-modified, tanshinone IIA-loaded lipid-polymeric nanocarriers for the targeted therapy of myocardial infarction.
Topics: Abietanes; Animals; Cell Death; Cell Survival; Drug Carriers; Drug Liberation; Endocytosis; Lipids; Molecular Targeted Therapy; Myocardial Infarction; Nanoparticles; Onium Compounds; Organophosphorus Compounds; Particle Size; Proton Magnetic Resonance Spectroscopy; Rats, Sprague-Dawley; Static Electricity; Tissue Distribution; Vitamin E | 2018 |